Skip to main content
. 2018 Mar 14;138(3):186–194. doi: 10.1111/ane.12920

Figure 1.

Figure 1

Patient disposition during the retrospective observation period. ADR, adverse drug reaction; OP, observational point. aFull Analysis Set includes seven patients with a daily lacosamide dose >400 mg/d. bSeven patients discontinued lacosamide monotherapy due to ADRs. Six patients stopped lacosamide completely and one patient remained on lacosamide adjunctive therapy. cIncludes lost to follow‐up (n = 11, 2.5%), non‐compliance (n = 3, 0.7%), withdrawal (n = 1, 0.2%) and one patient who did not have any seizures. dOP3: 12 months ± 3 months